PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

EFPIA Pledges Continued Support for TTIP

New Challenge to IP Innovation

Compliance in the 21^st Century: Pharm Exec's New eBook

Top Story

Is Pharma Prepared? The Lowdown on Brexit

As the UK exits the European Union, pharma should prepare for changes by identifying key business issues, mitigating risks and creating plans for multiple scenarios
... /Read more/

Podcast: Assuring Trust in the Digital Space
Pharm Exec talks to Mollie Shields-Uehling, a leading advocate for high-assurance identity trust for cyber-transactions in the biopharmaceutical industry. Listen to the podcast for a timely, 15-minute discussion covering topics like cyber/technical security; eHealth regulatory compliance; work flow automation, the benefits of eSignature programs, and collaboration around key aspects of drug development like the administration of clinical trials and research partnering.

Click here to listen

NICE Sets Out Proposed Technology Assessment Fees

Leela Barham looks at the potential cost to industry of the National Institute for Health and Care Excellence's plans to charge for TAs
... /Read more/

Technology can't replace people- why Patient Support Programs need a personal approach
Live Webcast: Thursday, September 29 at 8:00 EDT

Free registration

Social Media & Marketing

Content Marketing: Too Big to Ignore

It's safe to say content marketing is here to stay. So what is pharma doing with it? Less than it should be, writes Peter Houston
... /Read more/

Optimizing real-world evidence programs to generate value
Tailored approaches for emerging biopharma
Live Webinar: Wednesday, September 14 at 10:00am EDT

From the Editor

Rise of the Vox Populi

Big pharma has become increasingly vulnerable to larger geopolitical and macroeconomic risks—a realization that has slowly creeped into their business planning
... /Read more/

Breaking the Circle of Distrust with a Radical PLC Pricing Model
On Demand

Learn more

Calendar

/ September 15–16: Compliance Congress for Specialty Products /

Boston, MA

/ October 5: Drug, Chemical & Associated Technology Association (DCAT) After the Show /

Barcelona, Spain

/ October 27–28: MedComm 2016 /

San Francisco, CA

/ December 13–14: Life Sciences Trade and Channel Strategies /

Philadelphia, PA

/ February 07–08, 2017: Speaker Programs 2017 /

Philadelphia, PA

Best Practices for Integrating Biomarkers across the Drug Development Continuum
On Demand

Learn more

Industry update

//Marielle Cohard-Radice, M.D., was promoted to Executive Vice President, Global Head of Development at Daiichi Sankyo (Edison, NJ). She replaces Mahmoud Ghazzi, who is leaving the company.//Oncorus, Inc. (Cambridge, MA), a new immuno-oncology company, appointed Cyrus D. Mozayeni, M.D., as President and Chief Business Officer. //AMAG Pharmaceuticals, Inc. (Waltham, MA) announced the appointment of Tony Casciano to Senior Vice President of Sales and Marketing for the company's hematology and oncology business.//Marinus Pharmaceuticals, Inc. (Radnor, PA) appointed Seth H.Z. Fischer to its Board of Directors.//

advertise with us / print subscribe / digital subscribe / visit pharmexec.com